ArticleDiabetes, obesity & metabolism2026
Association of Physical Activity With All-Cause and CVD Mortality Across Metabolic and Obesity Phenotypes.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of Physical Activity With All-Cause and CVD Mortality Across Metabolic and Obesity Phenotypes.Diabetes, obesity & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo examine the independent and joint associations of metabolic status, obesity, and physical activity with all-cause and cardiovascular disease (CVD) mortality across metabolic-obesity phenotypes. MATERIALS AND
methodsWe analysed 442 666 adults from the Korean National Health Insurance Service health screening cohort (2009-2012). Metabolic status was defined using modified NCEP-ATP III criteria (elevated triglycerides, low HDL-C, elevated blood pressure or antihypertensive use, and elevated fasting glucose or antidiabetic use); ≥ 2 abnormalities indicated metabolically unhealthy. Obesity was defined as BMI ≥ 25 kg/m
resultsIn the primary multivariable model (Model 2a), compared with MHL, MUHL had the highest all-cause mortality (HR 1.23, 95% CI 1.19-1.26), whereas MUHO was not significantly associated with all-cause mortality (HR 0.97, 95% CI 0.94-1.01), and MHO showed lower risk (HR 0.85, 95% CI 0.81-0.89). Higher physical activity was consistently associated with lower all-cause and CVD mortality in a dose-response manner, and joint analyses showed progressively lower mortality across all metabolic-obesity phenotypes with increasing activity levels.
conclusionsMetabolic-obesity phenotypes were associated with differential mortality risk, and higher physical activity was associated with lower all-cause and CVD mortality across phenotypes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.